When Lymphoma Masquerades as Kidney Disease: A Rare Case of Light Chain Amyloidosis
A rare case report describes severe renal light chain amyloidosis arising from low-grade B-cell non-Hodgkin lymphoma, diagnosed through renal biopsy ...
Tag: non-Hodgkin lymphoma
Enhanced CAR T-Cell Therapy Shows Promise in Trial for B-Cell Blood Cancers
A phase I trial at Ohio State found that CAR T cells engineered to target three B-cell proteins and boosted ...
Energy Transfer and Sunoco Give Record $2.2 Million to MD Anderson Pediatric Cancer Research
Energy Transfer and its partnerships, including Sunoco and USA Compression, have donated a record $2.2 million from their annual employee ...
Rare Thyroid Lymphoma Returns Six Years Later — and a New Drug Regimen Beats It Back
A new case report in the Annals of Hematology describes a woman whose rare primary thyroid diffuse large B-cell lymphoma ...
CytoVI: Deep learning model unifies antibody-based single-cell data across platforms
Researchers have developed CytoVI, an open-source deep generative model that integrates, denoises and imputes antibody-based single-cell data from flow cytometry, ...
Immunophenotypic Markers Reveal Poor Survival in Ghanaian Children With Non-Hodgkin Lymphoma
A Ghanaian study of 38 children with non-Hodgkin lymphoma found that BCL-2 expression and tumor spread significantly predicted survival, with ...
Blood Protein Surge Reveals Nerve Damage From Common Lymphoma Chemotherapy
A prospective cohort study found that plasma neurofilament light chain rose roughly fourfold during vincristine chemotherapy in adults with non-Hodgkin ...
Rituximab-Lenalidomide Combo Matches Standard Therapy in Follicular Lymphoma, Meta-Analysis Finds
A new meta-analysis of four randomized trials finds that rituximab plus lenalidomide offers efficacy broadly comparable to standard chemoimmunotherapy in ...
Lymphoma Rates Are Quietly Rising Across Iran, National Registry Data Reveal
A national registry analysis of more than 18,000 Iranian cases shows Hodgkin and non-Hodgkin lymphoma incidence rising between 2014 and ...
Antibody-Drug Conjugate Combo Delivers 92.6% Complete Response Rate in Low-Risk Lymphoma Patients
A multicenter Chinese real-world study found that the antibody-drug conjugate regimen Pola-R-CHP achieved a 92.6 percent complete response rate in ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!